Rossari Biotech Limited (ROSSARI.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-31.0%

₹282.14

vs ₹409.05 price

Levered DCF

-₹431.49

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

3.14

Safe zone

Rating

B+

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	14.05×	24.98×	29.57×	30.63×	51.18×	66.47×	55.26×	78.56×
P/B	1.57×	2.88×	3.69×	3.59×	6.21×	13.06×	12.58×	28.99×
P/S	0.87×	1.64×	2.11×	1.98×	3.37×	7.55×	6.03×	7×
EV / EBITDA	8.53×	13.47×	15.39×	15.53×	25.66×	40.65×	33.59×	45.69×
Gross margin	20.6%	31.1%	28.8%	16.9%	15.4%	32.3%	36.3%	32.3%
Operating margin	8.6%	24.7%	10.2%	9.4%	8.9%	14.4%	14.7%	12.8%
Net margin	6.2%	6.6%	7.1%	6.5%	6.6%	11.3%	10.9%	8.9%
Current ratio	1.57×	1.94×	1.99×	2.08×	2.07×	2.36×	2.19×	1.31×
Debt / equity	0.33×	0.18×	0.11×	0.08×	0.01×	0×	0.23×	0.04×
Interest coverage	7.24×	28.9×	9.63×	6.95×	10.43×	33.93×	24.73×	22.81×
Dividend yield	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.1%	0.3%
Payout ratio	1.9%	2.0%	2.1%	2.6%	2.8%	3.2%	4.1%	23.2%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	11.2%	11.5%	12.5%	11.7%	12.1%	19.6%	22.8%	36.9%
Return on invested capital	8.4%	26.0%	11.2%	10.9%	9.8%	18.5%	18.5%	35.9%
Return on assets	6.5%	7.2%	8.3%	7.8%	7.8%	14.3%	13.8%	18.3%
Free cash flow yield	-10.5%	-0.6%	-2.3%	3.6%	-0.2%	-0.2%	-0.6%	0.8%
Earnings yield	7.1%	4.0%	3.4%	3.3%	2.0%	1.5%	1.8%	1.3%
Enterprise value	₹24.4B	₹35.7B	₹39.6B	₹32.9B	₹49.7B	₹53.2B	₹36.4B	₹35.9B
Net debt / EBITDA	1.2×	0.61×	0.36×	0.02×	-0.15×	-0.12×	0.35×	-0.02×
Cash conversion cycle (days)	101	101	103	80	77	48	20	16